Study of Epratuzumab in Systemic Lupus Erythematosus
Clinical trial NCT00111306 · TERMINATED
Trial details
- NCT number
- NCT00111306
- Sponsor
- UCB Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-03-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.